N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide

C29H37N7O7S2 — CID 137342942

IUPACN-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide
SMILESCC(C)C[C@@H]1NC(=O)c2coc(n2)[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCNS(C)(=O)=O)CCNC(=O)c2csc1n2
InChIInChI=1S/C29H37N7O7S2/c1-18(2)13-21-29-35-23(17-44-29)26(39)30-11-12-36(25(38)9-10-31-45(3,41)42)15-24(37)32-20(14-19-7-5-4-6-8-19)28-34-22(16-43-28)27(40)33-21/h4-8,16-18,20-21,31H,9-15H2,1-3H3,(H,30,39)(H,32,37)(H,33,40)/t20-,21-/m0/s1
InChIKeyXLXSSXIQJCNTNV-SFTDATJTSA-N
MW659.79 g/mol
LogP1.56
Rot. Bonds8

About N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide

N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide (PubChem CID 137342942) has the molecular formula C29H37N7O7S2 and a molecular weight of 659.79 g/mol. Its IUPAC name is N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide.

Molecular Properties

Compound NameN-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide
PubChem CID137342942
Molecular FormulaC29H37N7O7S2
Molecular Weight659.79 g/mol
Exact Mass659.22
IUPAC NameN-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide
SMILESCC(C)C[C@@H]1NC(=O)c2coc(n2)[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCNS(C)(=O)=O)CCNC(=O)c2csc1n2
InChIInChI=1S/C29H37N7O7S2/c1-18(2)13-21-29-35-23(17-44-29)26(39)30-11-12-36(25(38)9-10-31-45(3,41)42)15-24(37)32-20(14-19-7-5-4-6-8-19)28-34-22(16-43-28)27(40)33-21/h4-8,16-18,20-21,31H,9-15H2,1-3H3,(H,30,39)(H,32,37)(H,33,40)/t20-,21-/m0/s1
InChIKeyXLXSSXIQJCNTNV-SFTDATJTSA-N
XLogP1.56
TPSA192.70 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds8
Heavy Atoms45
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500659.79
LogP ≤ 51.56
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Analyze N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide?
The IUPAC name of N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide (CID 137342942) is N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide.
What is the SMILES notation for N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide?
The canonical SMILES for N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide is CC(C)C[C@@H]1NC(=O)c2coc(n2)[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCNS(C)(=O)=O)CCNC(=O)c2csc1n2.
What is the InChIKey of N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide?
The InChIKey is XLXSSXIQJCNTNV-SFTDATJTSA-N. The full InChI is InChI=1S/C29H37N7O7S2/c1-18(2)13-21-29-35-23(17-44-29)26(39)30-11-12-36(25(38)9-10-31-45(3,41)42)15-24(37)32-20(14-19-7-5-4-6-8-19)28-34-22(16-43-28)27(40)33-21/h4-8,16-18,20-21,31H,9-15H2,1-3H3,(H,30,39)(H,32,37)(H,33,40)/t20-,21-/m0/s1.
What are the key properties of N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide?
N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide has a molecular weight of 659.79 g/mol, XLogP of 1.56, 8 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[(4S,17S)-17-benzyl-4-(2-methylpropyl)-2,9,15-trioxo-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-3-oxopropyl]methanesulfonamide is sourced from PubChem (CID 137342942), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).